Valuation: Novartis AG

Market Cap 299B 262B 244B 224B 421B 28,627B 427B 2,904B 1,134B 14,135B 1,121B 1,096B 48,857B P/E 2026 *
22.3x
P/E 2027 * 19x
Enterprise Value 332B 292B 271B 249B 468B 31,802B 474B 3,226B 1,260B 15,704B 1,245B 1,218B 54,277B EV / Sales 2026 *
5.76x
EV / Sales 2027 * 5.34x
Free-Float
91.66%
Yield 2026 *
2.78%
Yield 2027 * 2.9%
1 day+1.63%
1 week+3.87%
Current month+3.02%
1 month+3.33%
3 months+13.67%
6 months+14.19%
Current year+18.98%
1 week 122.56
Extreme 122.56
131.28
1 month 121.06
Extreme 121.06
131.28
Current year 107.68
Extreme 107.68
131.28
1 year 91.56
Extreme 91.56
131.28
3 years 81.1
Extreme 81.1
131.28
5 years 72.84
Extreme 72.84
131.28
10 years 65.09
Extreme 65.09
131.28
Manager TitleAgeSince
Chief Executive Officer 50 31/01/2018
Director of Finance/CFO - 15/03/2026
Chief Tech/Sci/R&D Officer 64 15/05/2022
Director TitleAgeSince
Director/Board Member 67 31/12/2014
Director/Board Member 69 31/12/2015
Director/Board Member 61 31/12/2015
Date Insider Type Main position Quantity % Market Cap.
18/05/26 Sell -5,200 0.0003%
04/05/26 Sell 6,800 0.0003%
17/02/26 Sell 30,743 0.0015%
Change 5-day change 1-year change 3-year change Capi.($)
+1.46%+3.87%+39.70%+44.49% 299B
+1.68%+3.55%+50.62%+165.47% 1,068B
+1.15%+7.46%+62.01%+54.34% 641B
+3.07%+3.52%+40.63%+75.75% 454B
+2.17%+10.22%+41.17%+36.56% 351B
+0.40%+3.59%+19.93%+17.02% 266B
+2.73%+3.50%-25.66%-36.53% 220B
+3.87%+6.71%+29.71%+65.33% 203B
+2.05%+2.43%+18.06%+73.62% 162B
+2.01%+0.72%+3.33%-30.36% 141B
Average +2.12%+2.28%+27.95%+46.57% 380.39B
Weighted average by Cap. +1.97%+2.67%+38.81%+76.10%

Financials

2026 *2027 *
Net sales 57.58B 50.62B 47.12B 43.28B 81.26B 5,522B 82.33B 560B 219B 2,727B 216B 212B 9,425B 61.12B 53.73B 50.02B 45.94B 86.26B 5,862B 87.39B 595B 232B 2,894B 229B 225B 10,004B
Net income 13.78B 12.11B 11.28B 10.36B 19.45B 1,322B 19.7B 134B 52.35B 653B 51.73B 50.62B 2,255B 15.36B 13.5B 12.57B 11.54B 21.67B 1,473B 21.96B 149B 58.34B 727B 57.65B 56.41B 2,514B
Net Debt 33.11B 29.11B 27.1B 24.89B 46.73B 3,176B 47.35B 322B 126B 1,568B 124B 122B 5,420B 27.82B 24.45B 22.76B 20.91B 39.26B 2,668B 39.77B 271B 106B 1,317B 104B 102B 4,553B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
28/07/26 CHF 130.40 +1.46% 2,558,238
27/07/26 CHF 128.52 +1.28% 2,435,055
24/07/26 CHF 126.90 -0.60% 1,859,367
23/07/26 CHF 127.66 +1.85% 2,482,939
22/07/26 CHF 125.34 -0.16% 2,648,334
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
157.05USD
Average target price
153.99USD
Spread / Average Target
-1.95%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock